According to internet information statistics, the amount of data generated globally is expected to exceed 175ZB this year, ...

Fear and Greed Index drops to 39 despite a favorable macro backdrop. Bitcoin ETFs took in $440 million last week as investors bought the dip. A bearish breakout below $110K risks a bigger drop to ...

As a small business owner, Liz understands the unique challenges entrepreneurs face. Well-versed in the digital landscape, she combines real-world experience in website design, building e-commerce ...

New Delhi, September 4, 2025 (ANI): After the 56th GST Council meeting, Union Finance Minister Nirmala Sitharaman said “Reduction from 28 % to 18%- Air conditioning machines, TVs which are over 32 ...

Bitcoin price is down 11% from its all-time high, dropping to $111,000 on Monday. $108,000 is a short-term target for the bears, with some BTC analysts predicting a drop to $95,000. Bitcoin (BTC) ...

In the latest trading session, VALE S.A. (VALE) closed at $10.17, marking a -1.07% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.69%. Elsewhere, the Dow ...

The dollar index rose about 0.30 per cent, weighing on gold prices. Since gold is traded in the US dollar, a stronger US currency makes it expensive in other currencies, causing demand fatigue.

AI-generated summary reviewed by our newsroom. Read our AI Policy. FDA revoked emergency use for most COVID vaccines, limiting eligibility groups. Blue Cross NC may change coverage pending CDC ...

The percentage of GCSE students achieving a standard pass has fallen slightly this year, sparking renewed concerns over the number of young people in England who may now be required to resit their ...

Okta (OKTA) closed at $89.83 in the latest trading session, marking a -1.32% move from the prior day. This move lagged the S&P 500's daily loss of 0.4%. At the same time, the Dow lost 0.34%, and the ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...